BioNTech (BNTX) PT Lowered to $254 at BofA Securities
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $110.89 -1.97%
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
17 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
BofA Securities analyst Tazeen Ahmad lowered the price target on BioNTech (NASDAQ: BNTX) to $254.00 (from $255.00) while maintaining a Neutral rating.
You May Also Be Interested In
- Unicycive Therapeutics (UNCY) PT Raised to $15 at Benchmark Following Q2 Results
- Freedom Broker Upgrades Taylor Devices, Inc. (TAYD) to Buy
- Nutanix (NTNX) PT Raised to $80 at Oppenheimer Into EPS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
